Effect of recombinant human erythropoietin on endothelial cell apoptosis

Kidney International

Volumn 55, Issue 2, 1999, Pages 546-553

  Carlini, Raul G ^a,b   Alonzo, Evelyn J ^a,b   Dominguez, Jose ^a,b   Blanca, Isaac ^a,b   Weisinger, Jose R ^a,b   Rothstein, Marcos ^a,b   Bellorin Font, Ezequiel ^a,b,c  

^a HOSPITAL UNIVERSITARIO DE CARACAS   (Venezuela)

^b BARNES JEWISH HOSPITAL   (United States)

^c Plaza las Americas 1061 A ^*  (Venezuela)

Author keywords

Angiogenesis; Cell growth; Lipopolysaccharide; Programmed cell death; rHuEPO

Indexed keywords

DNA FRAGMENT; LIPOPOLYSACCHARIDE; RECOMBINANT ERYTHROPOIETIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CATTLE; CELL SURVIVAL; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GEL ELECTROPHORESIS; NONHUMAN; PRIORITY JOURNAL; STAINING;

EID: 0032954070     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00266.x     Document Type: Article

References (29)

1. 1. MAJNO G, JORIS I: Apoptosis oncosis and necrosis: An overview of cell death. Am J Pathol 146:3-15, 1995
2. 2. MARTI A, JOHN B, COSTELLO E, KEON N, KE G, MARTIN F, JAGGI R: Protein kinase A and AP-1 (c-Fos/JunD) are induced during apoptosis of mouse mammary epithelial cells. Oncogene 9:1213-1223, 1994
3. 3. O'SHEA JD, HAY MF, CRAN DG: Ultrastructural changes in the theca interna during follicular atresia in sheep. J Reprod Fertil 54:183-187, 1978
4. 4. LEDDA-COLUMBANO GM, COLUMBANO A: Apoptosis and hepato-carcinogenesis, in Apoptosis: The Molecular Basis of Cell Death, edited by TOMEI LD, COPE FO, Plainview, Cold Spring Harbor Laboratory Press, 1991, pp 101-119
5. 5. WILLIAMS GT, SMITH CA, SPOONCER E, DEXTER TM, TAYLOR DR: Haematopoietic colony stimulating factors promote cell survival by suppressing apoptosis. Nature 343:76-79, 1990
6. 6. SAWADA K, KRANTZ SB, DESSYPRIS EN, KOURY ST, SAWYER ST: Human colony-forming units-erythroid do not require accessory cells, but do require direct interaction with insulin-like growth factor I and/or insulin for erythroid development. J Clin Invest 83:1701-1709, 1989
7. 7. KOURY MJ, BONDURANT MC: Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. Science 248:378-381, 1990
8. 8. HARLAN JM, HARKER LA, REIDY MA, GAJDUSEK CM, SCHWARTZ SM, STRIKER GE: Lipopolysaccharide-mediated bovine endothelial cell injury in vitro. Lab Invest 48:3269-3274, 1983
9. 9. HOYT DG, MANNIX RJ, RUSNAK JM, PITT BR, LAZO JS: Collagen is a survival factor against LPS-induced apoptosis in cultured sheep pulmonary endothelial cells. Am J Physiol 269(Lung Cell Mol Physiol 13):L171-L177, 1995
10. 10. TSUKADA T, EGUCHI K, MIGITA K, KAWABE Y, KAWAKAMI A, MATSUOKA N, TAKASHIMA H, MIZOKAMI A, NAGATAKI S: Transforming growth factor β1 induces apoptotic cell death in cultured human endothelial cells with down-regulated expression of BCL-2. Biochem Biophys Res Commun 210:1076-1082, 1995
11. 11. ARAKI S, ISHIDA T, YAMAMOTO T, KAJI K, HAYASHI H: Induction of apoptosis by hemorrhagic snake venom in vascular endothelial cells. Biochem Biophys Res Commun 190:148-153, 1993
12. 12. KOURY MJ, BOUDURANT MC: Maintenance by erythropoietin of viability and maturation of murine erythroid precursor cells. J Cell Physiol 137:65-74, 1988
13. 13. ANAGNOSTOU A, LEE ES, KESSIMIAN N, LEVINSON R, STEINER M: Erythropoietin has a mitogen and positive chemotactic effect on endothelial cells. Proc Natl Acad Sci USA 87:5978-5982, 1990
14. 14. ANAGNOSTOU A, LIU Z, STEINER M, CHIN K, LEE ES, KESSIMIAN N, NOGUCHI CT: Erythropoietin receptor mRNA expression in human endothelial cells. Proc Natl Acad Sci USA 91:3974-3978, 1994
15. 15. HEIDENREICH S, RAHN KH, ZIDEK W: Direct vasopressor effect of recombinant human erythropoietin on renal resistance vessels. Nephrol Dial Transplant 5:739-740, 1990
16. 16. AMMARGUELLAT F, GOGUSEV J, DRUEKE TB: Direct effect of erythropoietin on rat vascular smooth-muscle cell via a putative erythropoietin receptor. Nephrol Dial Transplant 11:687-692, 1996
17. 17. CARLINI RG, DUSSO AS, OBIALO CI, ALVAREZ UM, ROTHSTEIN M: Recombinant human erythropoietin (rHuEPO) increases endothelin-1 release by endothelial cells. Kidney Int 43:1010-1014, 1993
18. 18. NAGAY T, AKIZAWA T, NAKASHIMA Y, KOHJIRO S, NABESHIMA K, KANAMORI N, TAKAYAMA K, KINUGASA E, KOSHIKAWA S: Effects of rHuEPO on cellular proliferation and endothelin-1 production in cultured endothelial cells. Nephrol Dial Transplant 10:1814-1819, 1995
19. 19. CARLINI R, REYES A, ROTHSTEIN M: Recombinant human erythropoietin stimulates angiogenesis in vitro. Kidney Int 47:740-745, 1995
20. 20. FREY EA, FINLAY BB: Lipopolysaccharide induces apoptosis in bovine endothelial cell line via a soluble CD 14 dependent pathway. Microb Pathog 2:101-109, 1998
21. 21. KELLY LL, GREEN WF, HICKS GG, BONDURANT MC, KOURY MJ, RULEY HE: Apoptosis in erythroid progenitors deprived of erythropoietin occurs during the G1 and S phase of the cell cycle without growth arrest or stabilization of wild-type p53. Mol Cell Biol 14:4183-4192, 1994
22. 22. SILVA M, GRILLOT D, BENITO A, RICHARD C, NUÑEZ G, FERNANDEZ-LUNA JL: Erythropoietin can promote erythroid progenitor survival by repressing apoptosis through Bcl-XL and Bcl-2. Blood 88:1576-1582, 1996
23. 23. HALLER H, CHRISTEL C, DANNENBER L, THIELE P, LINDSCHAU C, LUFT FC: Signal transduction of erythropoietin in endothelial cells. Kidney Int 50:481-488, 1996
24. 24. CHOI ME, BALLERMANN BJ: Inhibition of capillary morphogenesis and associated apoptosis by dominant negative mutant transforming growth factor-beta receptor. J Biol Chem 36:21144-21150, 1995
25. 25. GRIS JC, BRANGER B, VECINA F, SABADANI B, FOURCADE J, SCHVED JF: Increased cardiovascular risk factors and features of endothelial activation and dysfunction in dialyzed uremic patients. Kidney Int 46:807-813, 1994
26. 26. MAKAYAMA M, YAMADA K, YAMAMOTO Y, YOKOYAMA K, NAKANO H, KUBO H, SHIGEMATSU T, KAWAGUCHI Y, SAKAI O: Vascular endothelial dysfunction in patients on regular dialysis treatment. Clin Nephrol 42:117-120, 1994
27. 27. ISEKI K, NISHIME K, UEHARA H, TOKUYAMA K, TOMA S, YOSHIHARA K, KOWATARI T, TERUKINA S, OSAWA A, FUKIYAMA K: Increased risk of cardiovascular disease with erythropoietin in chronic dialysis patients. Nephron 72:30-36, 1996
28. 28. LUNDIN AP, FANI K, BERLYNE GM, FRIEDMAN EA: Dermal angiopathy in hemodialysis patients: The effect of time. Kidney Int 47:1775-1780, 1995
29. 29. KURIYAMA S, HOPP L, YOSHIDA H, HIKITA M, TOMONARI H, HASHIMOTO T, SAKAI O: Evidence for amelioration of endothelial cell dysfunction by erythropoietin therapy in predialysis patients. Am J Hypertens 9:426-431, 1996